Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cambrex Corp (NYSE:CBM)

49.90
Delayed Data
As of 4:03pm ET
 +0.20 / +0.40%
Today’s Change
42.55
Today|||52-Week Range
62.95
-7.51%
Year-to-Date
No recent news for Cambrex Corp.

Today’s Trading

Previous close49.70
Today’s open50.05
Day’s range49.75 - 50.10
Volume5,524
Average volume (3 months)381,759
Market cap$1.6B
Data as of 4:03pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)+40.91%
Earnings growth (this year)+7.93%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+13.23%
P/E ratio16.4
Price/Sales3.63
Price/Book3.96

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...+0.97+3.64%
CORTCorcept Therapeutics...+0.09+0.52%
ARRYArray Biopharma Inc+0.70+6.47%
RGENRepligen Corp-0.24-0.67%
Data as of 4:06pm ET, 12/13/2017

Financials

Next reporting dateFebruary 7, 2018
EPS forecast (this quarter)$1.13
Annual revenue (last year)$490.6M
Annual profit (last year)$81.7M
Net profit margin17.80%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
President, Chief Executive Officer &
Director
Steven M. Klosk
Chief Operating Officer &
Executive Vice President
Shawn P. Cavanagh
Corporate headquarters
East Rutherford, New Jersey

Forecasts